|
Anormed Completes Enrollment in Phase III Trial for Mozobil on Schedule AnorMED Inc. has announced that it has completed enrollment in the second pivotal Phase III clinical trial evaluating its proprietary product MOZOBIL in cancer patients, and that the Company is on track to meet its schedule of releasing top-line data from both Phase III trials in the first half of 2007.
Patient's Own Blood Cells Treat Tennis Elbow Using patients' own platelets, doctors report they were able to successfully treat tennis elbow.
Multi-Center Study Concludes Nephros Mid-Dilution Hemodiafiltration Therapy Achieves Higher Clearance of Low Molecular Weight Proteins Nephros, Inc. has announced that the results of a randomized, multi-site scientific study indicate that the Company’s Mid-Dilution Hemodiafiltration (Mid-HDF) therapy, using its OLpur MD 190 filter, offers the advantages of both pre- and post-HDF, and is "the most efficient dialysis procedure for Low-Molecular Weight Protein removal."
Early Catheter Replacement Better Than Delayed Replacement in Hemodialysis Patients With Catheter-Related Infection Catheters can be removed early on with no additional risk of infection in dialysis patients who have had catheter-related infection (CRI), according to results of a small randomized study presented at the 44th annual meeting of the Infectious Diseases Society of America (IDSA).
New Device Utilizes Beam of Light to Test Blood Cheaply, Quickly A scientist and a doctor have collaborated on the development of a new device that tests blood for diseases quickly by shining a beam of light into a sample of blood, said to be cheaper and easier than standard diagnostic tests and to eliminate the need to send samples to a lab.
Code Scanning Boosts Safety A hand-held computer prevents potentially fatal accidents by matching patients to blood products before allowing transfusions to start and has been proven a complete success during pilot trials at the John Radcliffe in Headington.
Hydromer, Inc. Announces a Non-Leaching Anti-Thrombogenic Coating for Evaluation The surface bonding capabilities of the F202 polymer, which maintains long-term non-leaching properties, are outstanding on a wide variety of medical materials such as cardiovascular devices and stents, hemodialysis equipment and intravenous catheters.
Study Shows Nearly One In Five People Plan To Donate Blood In The Next Year Donating the most needed component(s)," such as red blood cells and platelets, was the primary reason mentioned by more than 50 percent of respondents who intended to make their next donation on an automated collection system.
Demand for Platelets up 50% in 5 Years The demand for platelets - vital components of blood used in the treatment of cancer - has increased by 50% over the last five years, the Irish Cancer Society (ICS) has said.
Irish Blood Bank Considers New vCJD Blood Filter Trial The Blood Bank has said it may consider proceeding with its own clinical trial of a new filter to remove the infectious agent believed to carry vCJD in blood, following the halting of an unrelated earlier trial.
Blood Transfusions May Have Contained HIV, Hepatitis Due to Faulty Testing Kits West Bengalese patients who received blood transfusions from donation centers that used Monozyme India Private Ltd.'s faulty diagnostic device may have been exposed to HIV and hepatitis B and C viruses.
Korean Women May Have Been Exposed to Acitretin in Blood Transfusions The Korean National Red Cross has told approximately 400 Korean woman who received blood transfusions to avoid pregnancy for at least two years because they may have been exposed to Acitretin, which can cause birth defects.
A Reminder of Darker Days The events surrounding the blood scandal of the mid-1990s have re-emerged this week following the news that Crumlin Children's Hospital is recalling around 70 former patients who who were given blood products between 1991 and 1994 which were not adequately screened for Hepatitis C.
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
Cytapheresis in the Treatment of Cell-affected Blood Disorders and Abnormalities The report presents the researchers' experience with cytaphereses performed in treatment of 476 patients.
Overnight Storage of Autologous Stem Cell Apheresis Products Before Cryopreservation Does Not Adversely Impact Early or Long-term Engraftment Following Transplantation The results of the study suggest that overnight storage of the autograft before cryopreservation does not adversely affect graft viability or influence long-term disease status, and support the continued use of overnight storage of stem cells before cryopreservation as a convenient, cost reduction measure.
|